- call +1-201-465-4211
- email sales@mrinsights.biz
Colorectal cancer (CRC) is one of the “big four” tumor types, the third most common cancer to affect both men and women, and the third-leading cause of cancer-related death. The main differentiator between colon cancer and rectal cancer is the location of the primary tumor, but identical etiology and similar risk factors and symptoms mean that they are often grouped together.
Scope of the Report:
This report focuses on the Colon & Rectal Carcinoma in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Colon & Rectal Carcinoma is expected to grow at a CAGR of roughly 2.1% over the next five years, will reach 9630 million US$ in 2023, from 8500 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Bayer Healthcare
Spectrum
Novartis
Amgen
Roche
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Colon
Rectal
Market Segment by Applications, can be divided into
Hospital
Clinic
There are 15 Chapters to deeply display the global Colon & Rectal Carcinoma market.
Chapter 1, to describe Colon & Rectal Carcinoma Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Colon & Rectal Carcinoma, with sales, revenue, and price of Colon & Rectal Carcinoma, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Colon & Rectal Carcinoma, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Colon & Rectal Carcinoma market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Colon & Rectal Carcinoma sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Colon & Rectal Carcinoma Introduction
1.2 Market Analysis by Type
1.2.1 Colon
1.2.2 Rectal
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Colon & Rectal Carcinoma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer Healthcare
2.2.1 Business Overview
2.2.2 Colon & Rectal Carcinoma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Healthcare Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Spectrum
2.3.1 Business Overview
2.3.2 Colon & Rectal Carcinoma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Spectrum Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Colon & Rectal Carcinoma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Colon & Rectal Carcinoma Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Colon & Rectal Carcinoma Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Colon & Rectal Carcinoma Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Colon & Rectal Carcinoma Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Colon & Rectal Carcinoma Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Colon & Rectal Carcinoma Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Colon & Rectal Carcinoma Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Colon & Rectal Carcinoma Manufacturer Market Share in 2017
3.3.2 Top 6 Colon & Rectal Carcinoma Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Colon & Rectal Carcinoma Market Analysis by Regions
4.1 Global Colon & Rectal Carcinoma Sales, Revenue and Market Share by Regions
4.1.1 Global Colon & Rectal Carcinoma Sales and Market Share by Regions (2013-2018)
4.1.2 Global Colon & Rectal Carcinoma Revenue and Market Share by Regions (2013-2018)
4.2 North America Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
4.3 Europe Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
4.5 South America Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
5 North America Colon & Rectal Carcinoma by Countries
5.1 North America Colon & Rectal Carcinoma Sales, Revenue and Market Share by Countries
5.1.1 North America Colon & Rectal Carcinoma Sales and Market Share by Countries (2013-2018)
5.1.2 North America Colon & Rectal Carcinoma Revenue and Market Share by Countries (2013-2018)
5.2 United States Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
5.3 Canada Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
5.4 Mexico Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
6 Europe Colon & Rectal Carcinoma by Countries
6.1 Europe Colon & Rectal Carcinoma Sales, Revenue and Market Share by Countries
6.1.1 Europe Colon & Rectal Carcinoma Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Colon & Rectal Carcinoma Revenue and Market Share by Countries (2013-2018)
6.2 Germany Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
6.3 UK Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
6.4 France Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
6.5 Russia Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
6.6 Italy Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
7 Asia-Pacific Colon & Rectal Carcinoma by Countries
7.1 Asia-Pacific Colon & Rectal Carcinoma Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Colon & Rectal Carcinoma Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Colon & Rectal Carcinoma Revenue and Market Share by Countries (2013-2018)
7.2 China Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
7.3 Japan Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
7.4 Korea Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
7.5 India Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
8 South America Colon & Rectal Carcinoma by Countries
8.1 South America Colon & Rectal Carcinoma Sales, Revenue and Market Share by Countries
8.1.1 South America Colon & Rectal Carcinoma Sales and Market Share by Countries (2013-2018)
8.1.2 South America Colon & Rectal Carcinoma Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
8.3 Argentina Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
8.4 Colombia Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
9 Middle East and Africa Colon & Rectal Carcinoma by Countries
9.1 Middle East and Africa Colon & Rectal Carcinoma Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Colon & Rectal Carcinoma Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Colon & Rectal Carcinoma Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
9.3 UAE Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
9.4 Egypt Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
9.5 Nigeria Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
9.6 South Africa Colon & Rectal Carcinoma Sales and Growth Rate (2013-2018)
10 Global Colon & Rectal Carcinoma Market Segment by Type
10.1 Global Colon & Rectal Carcinoma Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Colon & Rectal Carcinoma Sales and Market Share by Type (2013-2018)
10.1.2 Global Colon & Rectal Carcinoma Revenue and Market Share by Type (2013-2018)
10.2 Colon Sales Growth and Price
10.2.1 Global Colon Sales Growth (2013-2018)
10.2.2 Global Colon Price (2013-2018)
10.3 Rectal Sales Growth and Price
10.3.1 Global Rectal Sales Growth (2013-2018)
10.3.2 Global Rectal Price (2013-2018)
11 Global Colon & Rectal Carcinoma Market Segment by Application
11.1 Global Colon & Rectal Carcinoma Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
12 Colon & Rectal Carcinoma Market Forecast (2018-2023)
12.1 Global Colon & Rectal Carcinoma Sales, Revenue and Growth Rate (2018-2023)
12.2 Colon & Rectal Carcinoma Market Forecast by Regions (2018-2023)
12.2.1 North America Colon & Rectal Carcinoma Market Forecast (2018-2023)
12.2.2 Europe Colon & Rectal Carcinoma Market Forecast (2018-2023)
12.2.3 Asia-Pacific Colon & Rectal Carcinoma Market Forecast (2018-2023)
12.2.4 South America Colon & Rectal Carcinoma Market Forecast (2018-2023)
12.2.5 Middle East and Africa Colon & Rectal Carcinoma Market Forecast (2018-2023)
12.3 Colon & Rectal Carcinoma Market Forecast by Type (2018-2023)
12.3.1 Global Colon & Rectal Carcinoma Sales Forecast by Type (2018-2023)
12.3.2 Global Colon & Rectal Carcinoma Market Share Forecast by Type (2018-2023)
12.4 Colon & Rectal Carcinoma Market Forecast by Application (2018-2023)
12.4.1 Global Colon & Rectal Carcinoma Sales Forecast by Application (2018-2023)
12.4.2 Global Colon & Rectal Carcinoma Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Colon & Rectal Carcinoma Picture
Table Product Specifications of Colon & Rectal Carcinoma
Figure Global Sales Market Share of Colon & Rectal Carcinoma by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
